Who Generates Higher Gross Profit? United Therapeutics Corporation or Bausch Health Companies Inc.

Bausch vs. United: A Decade of Gross Profit Trends

__timestampBausch Health Companies Inc.United Therapeutics Corporation
Wednesday, January 1, 201460089000001162636000
Thursday, January 1, 201578538000001396725000
Friday, January 1, 201670630000001526100000
Sunday, January 1, 201761760000001619600000
Monday, January 1, 201860290000001429100000
Tuesday, January 1, 201962510000001331200000
Wednesday, January 1, 202057780000001375200000
Friday, January 1, 202160400000001563000000
Saturday, January 1, 202257600000001789600000
Sunday, January 1, 202361980000002070000000
Loading chart...

In pursuit of knowledge

A Tale of Two Companies: Gross Profit Analysis

In the competitive landscape of the pharmaceutical industry, understanding which companies lead in profitability is crucial. Over the past decade, Bausch Health Companies Inc. and United Therapeutics Corporation have been key players. From 2014 to 2023, Bausch Health consistently outperformed United Therapeutics in gross profit, with an average of approximately 6.3 billion annually, compared to United Therapeutics' 1.5 billion. However, the gap has been narrowing. By 2023, United Therapeutics saw a significant increase, reaching 2.07 billion, marking a 78% growth from 2014. Meanwhile, Bausch Health's profits peaked in 2015 and have since stabilized. This trend suggests a dynamic shift in the market, with United Therapeutics gaining momentum. Investors and industry analysts should keep a close eye on these developments as they could signal future shifts in market leadership.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025